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THE development of the search for endogenic carcinogens has been reported
in earher publications from this Institute, (see Hieger (1949) for references to
previous papers). It has been shown that the cholesterol-rich fraction of'tissues
from humansubjects who had died of cancer or ofother causes, and even commer-
cial cholesterol. is a carcinogen. The present paper deals with the evidence for
the careinogemc activity of; the purified sterol itself.
It will be useful to firstpresent in greater detail the data for the results obtained
with commercial cholesterol before it has undergone any special purification, i.e.,
as bought. Table I and Summary to Table I show the survival rate and- tumour
incidence in the first series of tests.
Some of the experiments in Table I have been reported in the 1949 paper
(Hieger, 1949, p. 132, section 10d). They are repeated here especially to show
that when this particular series of test was extended (it was carried on over the
period 1944-1949) to further groups ofmice, and, moreover, with differentsamples
of commercial cholesterol, the activity of the sterol remained within the hmits
ofuncertainty characteristic of the tests with this substance, provided other con-
ditions remain unaltered.
AR
" tumours
" in this paper are sarcomas at the site ofinjection, usually of
spindle ceR type. Photomicrographs are show-n in the plates (Fig. I to 6). A
goodproportion ofthese sarcomastransplanted well. The first tumour in Table I
was carried through 93 generations and the first tumour in Table IV (highly purified cholesterol) has been growing vigorously in its 25th generation. The
latent period is in the neighbourhood of 19 months (Table IX). The technique
of assay has been to inject 0-1-0-4 c.c. of a 10 or 15 per cent solution of the sterol
subcutaneously into mice as often as is required to maintain a nodule under the
skin. On the average, each mouse received ofthe order of 3 to 5injectionsduring the course of the test which lasted from the time the m-ice were 6-10 weeks of
age until their death. In the earher tests lard, supplied.by a-singlefirm, was used
as the solvent, but in 1950 it was found that a large batch of lard from the same
source had different physical properties from the lard supplied until then, and it
was decided to change to olive ofl as solvent, although that alteration did not
guarantee that there would result a greater uniformity in the composition of the
solvent at future times. It would have been advantageous from some points of
view to have chosen a synthetic solvent such as tricaprylin, but since a naturally occurringfat, i.e., lard, had already been in use for a considerable time the change
to another naturally occurring fat, olive oil, was considered not to be as drastica change in techn'ique as would changing to a synthetic solvent. The control
tests on solvents are described further on in this paper.
Purification of the cholesterol was next undertaken, as a first step using the
simplest technique. Table II gives the results of tests on fractions of commercial
cholesterol obtained by crystalhsation from acetone. Some of these results were
given in a condensed form in the 1949 paper (Hieger, 1949) referred to above;
they are repeated here so that the results for the different fractions can be com-
pared.
TABLF, I.-Tests of Carcinogenic Activity of Commercial Cholesterol
(Solution in Lard).
This table is laid out in detail in order to show theexpectedly discrete andspasmodic
development of tumours which appear at a low incidence in a large series of animals.
Sarcoma development at site of injection is shown by a number in parenthesis
indicating the latent period in months.
Each line represents the events occurring in the same cage.
Number ofmice surviving.
r A_
Expt. Strain of Start
No. mouse. of expt. 6 m. 9 m. 1 yr. 15 m. 18 m. 21 m. 24 m. 27 m. 30 m. Sarconias.
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1 C57 CT 5
2 C57 5
3 C57 6
4 C57 6
5 CBA 5
6 CBA cT 5
7 C57 5
8 C57 6
9 C57 5
10 C57 5
11 C3H C. 5
12 C3H d 5
13 C57 C. 5
14 Stock cT 5
15 93, CT 5
16 5
17 5
18 5
19 cT 5
20 C57 O- 5
21 C57 CT 5
22 C57 3
23 Cr,7 4
24 C57 4
25 C57 4
26 C57 5
27 C57 5
28 C57 5
29 C57 5
30 C57 CT 5
31 C57 CT 5
32 Stock cT 5
33 9 91 ? 5
34 99 S 5
3.5 C.57 Y 5
36 MRC 5
37 .jl CT 5
38 991d - 5
39 311, 6 - 5
5
5
3
5
4
5
5
4
5
5
5
3
4
0
3
5
3
4
4
5
4
0
4
4
4
3
5
5
4
5
4
5
2
2
4
5
5
5
4
4
5
3
4
4
5
5
0
5
5
4
3
4
3
5
1
4
4
5
4
4
4
4
2
5
4
3
5
4
2
0
1
4
3
4
5
4
Ill
0
3
4
3
5
513
0
5
2
2
4
3
5
0
4
4
5
4
4
4
4
2
4
4
2
5
4
114
1
4
3
4
5
4
I
3
3
2
5
4
5
1
0
4
2
2
14216
315
5
4
4
4
3
2
3
3
0
5
4
0
1
4
3
3 .
3
0
0
3 3 240
0
0
2 0
4 1 0
220 122 0
0
4 0
0
2 1 0
0
2 1 0
4 4 3
218
4 4 3
4 4 2
3 223 0
1 1 0
218 0
0
5 5 4
4 3 0
124
4 323 2
3 2 0
2 223 0
3 323 2
0
0
0
0
0
0
2
0
0
0
0
0
0
0
0
0
3 0
0 0
0
0
0
229 1
0
0
0
0
0
0
0Number of xnice survivin.
t A
EXPLANATION OF PLATES.
FIG. I.-Sarcoma (No. 1) induced at site of injection in a C57 mouse, by olive oil solution of
highly purified cholesterol. x 90.
FIG. 2.-Sarcoma (No. 2) induced at site of injection in a C57 mouse, by olive oil solution of
highly purified cholesterol. x 90.
FIG. 3.-Sarcoma (No. 3) induced at site of injection in a C57 mouse, by olive oil solution of
highly purified cholesterol. x 90.
FIG. 4.-Sarcoma (No. 4) induced at site of injection in a C57 mouse, by olive oil solution of
highly purified cholesterol. x 90.
FIG. 5.-Sarcoma (No. 5) induced at site of injection in a C57 mouse, by olive oil solution of
highly purified cholesterol. x 90.
FIG. 6.-Sarcoma induced at site of injection in aC57 mouseby olive oil (controltest). x 90.
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SUMMARY OF TABLE I.-Carcinogenic Activity of Commercial Chole8terol
(Solution in Lard).
Attention is particularly drawn to columns 12 and 13. Obviously mice which die
before they reach the latent period should strictly speaking not be entered as having
been at risk. The figures in Column 12, therefore, give a lower apparent incidence
than is in fact the true incidence.
Incidence of
sarcoinas
calculated
per 100 effec-
tive mice at
ol A -I
Start 1 yr.
M. M.
(12) (13)
9-3 14
11 28
0
10 12
0
L9.
. Number
of
21 m. 24 m. 27 m. sarcomas.
(8) (9) (10) (11)
Strain
of
mouse.
(1)
C57
Stock
C3H .
MRC.
CBA .
r
Start
ofexpt.
(2)
108
45
10
20
10
6 m.
(3)
92
28
8
19
9
9 M.
(4)
83
20
7
16
9
1 yr.
(5)
68
18
4
16
8
15 m.
(6)
61
10
1
10
7
18 m.
(7)
45
5
0
8
2
27
5
7
1
10
3
2
0
6
1
0
10
5
0
2
0
TABLE II.
Activity of(1) fractions of commercial cholesterol obtained bycrystallising from acetone, (2) impurities in the same sample of commercial cholesterol
obtained in the mother hquors from the acetone crystallisation of the acetate.
These impurities still contain some cholesterol.
Number of mice surviving. -1 - - . . .
t A Latent
Mouse Start periods
strain. ofexpt. 6 m. 9 m. 1 yr. 15 m. 18 m. 21 m. 24 m. 27 m. 30 m. Sarcomas. (months).
. C,, . 15 . 13 13 13 13 13 11 6 2 0 . 2 . 23. 19
. Stock . 15 . 9 3 2 1 1 1 1 0 . 2 . 14,' 24
Expt. Material tefAted.
'Commercial cholesterol
(Expts. 30-35 from Table I) A - This test was carried out
during the same period
I ag B, C, D, E below
Least soluble fmction from C5, 10 9 9 8 7 6 2
B acetone crystallisation of Stock 15 6 5 5 4 4 1
the cholesterol used for.&
Moderately soluble fraction Ca., 11 4 4 4 4 4 3
c from same fractionation Stock 16 13 13 11 7 5 2
process which gave B
.D.Mother liquors from IB, C Ca 7 12 10 8 7 7 5 3
fractionation Stock 15 8 5 5 5 5 2
Impurities in the same C', 11 11 11 10 9 8 6
cholesterol asusedinA-D, Stock 11 6 6 4 4 3 1
removed in the mother
E liquorsfrom acetone crys-
talHsation of the acetate
(Preparation by Prof. C.
W. Shoppoe.)
2 0 - . I 18
0 - . 3 . 14, 18, 21
3 0 - . 0
2 0 - . 1 15
3 1 0 . 0
1 0 - . 0
3 0 - . 0
0 - . 0BRITISH JOUR14At OF CANCEIt. Vol. viii, 1.0- 2.
u
I
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A sample of pure cholesterol was prepared by Professor Shoppee using the
Schoenheimer technique (bromination). The results of the mouse tests are
shown in Table III.
TABLEIII.-Activity ofPurified Cholesterol (preparedbyProf. C. W.Shoppee).
Number of mice surviving.
r
A
Strain Start
of of
mouse. expt. 6 m. 9 M. 1 yr. 15 m. 18 m. 21 m. 24 m. 27 m. 30 m. Sarcomas.
Stock 5 4 4 4 4 3 2 2 1 0 I (27th
9 5 4 4 4 2 1 0 - month)
C57 5 4 3 2 2 2 0
9, 5 4 0 0
3'9' 5 4 5 5 5 4 4 0
5 3 3 3 3 0
Cholesterol was next purified on a large scale. The method involved several
stages. These were :
(1) Acetylation. This step provided several advantages, nameiy-
(a) the OH group was protected during bromination ;
(b) the acetate can be differentially eluted from A1203by mild eluents
the unacetylated sterol when absorbed on A1203 requires more
powerful eluents.
(2) Bromination, filtration and debromination.
(3) Adsorption onA1203colunin and elution withbenzene-pet. ether mixture.
(4) De-acetylation of the eluate by a mild saponifying agent (KHC03)-
(5) Crystalhsation from acetone.
The results ofthe mouse tests on thispurified cholesterol are show-n inTable IV.
This experiment was carried out at our Buckinghamshire laboratories in the
Hydrocarbon-Carcinogen free laboratory "; the mice were housed in the same
room as the control series (Table V) treated with the cholesterol before it had
undergone purification.
Atmosphericcarcinogen as apossiblefactor in the inductionofsubcutaneous 8al-COma8
The investigations were continued after 1949 at our country laboratories (at
Pollards Wood, Buckinghamshire), which are situated 20 miles from London and
could give an opportunity for carrying out this kind of work hi an atmosphere
probably less contaminated by carcinogens than at the Chester Beatty Institute
in London where carcinogens arefrequently used in different parts ofthebuilding.
Experiments at Pollards Wood are conducted in rooms which have never, inten-
tionally, contained carcinogens other than those of the sterol type. These labo-
ratories are reached over an open court-yard, 20 yards away from other mouse
rooms (referred to below as
" carcinogen room "), where the mice injected with
cholesterol arekept in boxes on the same racks as mice which are being treatedby
painting with potenthydrocarbon-type carcinogens (3: 4-benzpyrene ordimethyl-
benzanthracene). By this arrangement it was possible to carry out experiments
designed to test the effect ofatmospheric contamination by powerful carcinogens.
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There was, of course, noguarantee that contamination could have beencompletely
avoided in the
" carcinogen-free
" room ; for example, 'sawdust from a box
-containing benzpyrene-treated mice might accidentally be carried in to the non-
carcinogen room on the shoes of anyone who had walked through the carcinogen
room. However, the technicians who serviced the mice in the. carcmogen room
TABLE IV.-Activity, qf OliVe Oil 80IUtion of highly purified cholMterol : Te8t8 on
C57 inaice.
Sarcoma development at site of injection is indicated by a number in
parentheses showing the latent period in months.
Experiments at PoHard's Wood laboratory.
Numbe-r ofmice'surviving. Start -A Sarcomas.
ofexpt. 6 M. 9 M. I yr. 15 m. 18 m. 21 m. 24 m. 27 m. 30 m.
3 3 3 3 l 1 1 1 0 0
3 3 3 3 3 0 0
3 3 3 3 3 3 202 0 1 (C57 3 3 3 3 2 2 1 1 0 0
5 4 2 0 0
3 2 2 2 2 1 1 1 0 0
3 3 2 2 1 1 0 0
3 3 2 2 0 0
4 3 3 3 2 2 0 0
3 3 3 2 2 2 0 0
4 3 3 3 3 3 123 0 1 (C57 4 4 2 1 1 0 0
5 4 4 4 4 0 0
3 2 2 2 2 1 0 0
4 4 4 4 4 4 2 1 0 0
4 4 4 4 4 4 3 0 0
3 2 2 2 2 2 0 0
4 2 2 2 2 1 0 0
3 3 3 3 3 3 0 0
3 3 3 215 1 1 0 1 (C57 4 4 4 4 4 4 2 2 0
3 3 2 2 2 2 2 1 1 0 0
5 5 5 5 3 0 0
4 4 4 4 4 2 2 1 0 0
3 3 3 3 3 2 0 0
3 3 2 2 2 2 0 0
4 4 4 4 4 4 2 1 0 0
4 4 4 4 3 2 2 0 0
4 2 1 1 1 0 0
3 2 2 2 2 218 1 0 1 (C57 4 2 2 2 2 2 2 1 0 0
4 4 4 3 2 0 0
4 2 2 2 2 0 0
4 4 4 4 4 1 1 1 0 0
5 5 5 5 4 4 3 2 0
4 4 2 2 2 2 2 0 0
4 3 3 3 3 319 1 0 1 (C57 4 2 2 2 1 0 0
5 5 5 4 2 0 0
5 4 3 2 2 2 2 0 0
4 4 4 4 4 2 1 1 0 0
5 4 4 4 3 3 1 0 0
5 5 4 4 3 2 2 1
3 2 2 1 0
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were onlv allowed to handle the mice in the non-carcinogen room during a fort-
inight (vacation) per year, when the
" non-carcinogen
" techniciab was not
available.
More complete isolation ofthe
" non-carcinogen
" experiment could have been
achieved by having a self-contained unit, rooms, equipment, servicing an'd staff
completely separate from the main block of laboratories.
The results of the tests are shown in Table V.
The findings 'summarised in the foregoing tables suggest answers to a number
of questions on the subject of this paper. For example:
Injury per se, i.e., the pricking of the tissue, on injection, as a possible factor in
sarcoma production.
The mechanical trauma caused by the needle cannotbe animportant factor for
only .1 sarcoma appeared in over 360 mice, repeatedly injected with lard alone
(control) in one series of tests and only I in another control series of 134 mice
injected with olive oil alone. Moreover, the fatty solvent is more rapidly dis-
persed in the subcutaneous tissue than it is when loaded with 10-15 per cent of
sterol and. consequently the controls had more injections than the sterol injected
mice in order to maintain a stationary nodule.
Is the carcinogenic activity of commercial cholesterol due (a) to the sterol itself, or
(b) to highly active impurities ?
The evidence presented in Tables IV and V provides support for (a), i.e.,
cholesterol per se is the true carcinogen in the commercial product.
If the incidence of sarcomas be expressed as the ratio (percentage) of tumour
mice to injMted mice which survived to a minimal latentperiod level, say I year,
then the result can be stated thus : (a) Purified cholesterol gives rise to 4 per cent
sarcomas in Q,. mice, (b) the cholesterol before purification gave 6-4 per cent
(average of 7-9 'and 54 per cent) in stock mice ; in C, iiii'oe Qle yield was 3-6 per
cent but as this figure-depends upon onesolitary sarcoma it uld not be rehable
except for the striking fact that in a number of tests C51 mice have repeatedly
proved to be about half as sensitive to cholesterol as are stock mice (Table VI).
To assess the carcinogenic activity of a material by a number denoting the
ratio (as apercentage) oftumourbea-ring mice to the total number ofmice treated
cannot besatisfactory, forobviouslythemicewhic'hdie beforethe averageexpected
latent period cannot have had adequate exposure to the carcinogen. It would be
animprovement ifthe assay were calculated as thepercentage oftumours induced
in the mice which survive to the average latent period or at least to the minimum
latentperiod.
The data obtained from the experiments carried out withpurified sterol at the
Chester Beatty Institute (Table III) do not support the contention that .h,. carcinogenesis is due to the sterol, but it should be observed that some -disturb
factorsappeared in this test. The mice did not survivewell, and in fact the single
sarcoma appeared at the 27th month in the sole survivor of the 34 mice initioy injected withpurified cholesterol. Twenty-seven months is near the outsideilimit
oftherange oflatentperiodsfoundwiththecarcinogensofthe cholesterolcategpyy,, In an experiment with commercial cholesterol (Table II, Section A) 3 of the 4280 1. HIEGER AND S. F. D. ORR
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TABLEVI.-To Illustrate the Higher Respome of Stock Mice, as Compared with
C57 MCe, to ae Carcinogenic Action of Cholesterol.
The data are arranged in pairs W57 : Stock-C57 : Stock
-etc.). Anthe
mice within mch pair were 'mj'ected with the same material, kept in the same
room and fed the same diet.
Sarcomas Sarcomas
per 100 mice per 100 mice
Number Survived Number of initial surviving
Table. Strain. ofmice. 1 year. sarcomas. M 1 yr.
M
C57 108 68 10 9-3 14
Stock 45 18 5 11 28
II, C57 15 13 2 13 15
Section A Stock 15 2 2 13 100
II, C57 10 8 1 10 12
Section B Stock 15 5 3 20 60
V, C57 60 28 I 1-7 3-6
Sections A, B, C Stock 135 95 6 4-4 6-3
sarcomas had latent periods of 23, 24 and 29 months respectively. In the test
just discussed (Table 111) only 3 mice survived to 21 months, 2 to 24 months and
I to 27 months when it developed a sarcoma. It is quite possible that the sus-
,ceptible mice in this group died before the characteristic latent period had
elapsed. Table IX shows the distribution of latent periods of the sarcomas
discussed in. this paper.
Why one mouse should develop a sarcoma whfle others of the same batch of
similar stock or strain treated under the same conditions shouldnot, has still to be
explained. To say that the single positive mouse had the necessary degree of
susceptibihty does not, of course, advance the understanding of the difference.
It is highly probable that multiple factors are necessary for sarcoma induction.
with thistype ofcarcinogen. Seven suggest themselves, namely: susceptibihty
associatedwithstrain, sexandtheindividualanimal, en-Ndronmentalconditionssuch
asatmospheric and dietetic, the
" true
" potency ofthecarcinogen and the nature
of the vehicle for administration.
The effect of straindifferenceson8UWeptibility.
The summary ofTable1, Table V and Table VIillustrates' the effect on tumour
incidence of varying the strain of mouse while keeping other factors the same.
Table VI particularly shows that althoughtumour,yield varied, the relative order
ofsusceptibihty ofst'ck mice and0fC., mice remainedsubstaritially the same.
Could the injected cholesterol act as a reservoir for accumulating any circulating
carcinogen, either of endogenic or of exogenic origin?
This possibflity, which was put forward first by Kennaway in 1936 (unpub- lished) and by J. W. Orr in 1947 (unpubhshed), would provide an attractive
theory of the mode of action of cholesterol as carcinogen. However, it would be
necessary to postulate that the carcinogen is heldbyadsorption on the cholesterol292 1. HIhGEP. AND S. F. D. OP.P.
although stif in a-n active stage, and that in such- a condition it is not roadily
eluted, for clearly if it were a case of simple solubility there would be no more
reason for'the factor dissolving in the cholesterol than for it to be dissolved out
again. Secondly
i 'ected cholesterol after a year or so in the body should be
rich in absorbed carcinogen. Thirdly, ifsuch an assumption wereaccepted, there
would be httle necessity to proceed with the question of whether pure or impure
cholesterol is the true carcinogen. Fourthly, if the carcinogen'which is concen-
tratedinthe cholesteroloriginatedintheenvironment, it shouldbe easy to test the
hypothesis by purposely aRowing the mice injected with the cholesterol to hve
an atmosphere rich in carcinogen.
This test has been put into operation, and constitutes a secoind stage to the
investigation on atmospheric carcinogens as a factor in sarcoma induction (see
above).
One hundred stock mice were injected with ohve oil solution of commercial
cholesterol and kept in a carcinogen-rich atmosphere as described above. The
control mice (135) were kept in the room free from carcinogen.
The results are shown in Table V.
Control te8t8 on the 801vent8.
Lard was employed as solvent from 1936 to 1949. During this time a total of
over 360 mice was tested withthesolvent, lard'alone. These mice did not survive
remarkably well; they gave no positive result until the series had been almost
completed, when among the last few batches a single sarcoma developed. When
in 1950, a change was made from lard to olive oil (hospital dispensary grade),
a control series of 134 mice was set up for injection with the oil alone. A single
sarcoma was found in this series. A detailed analysis of these tests is shown in
Tables VII and VIII.
For the experiments described in Tables 1, II, and III and Flow Sheet I lard
was used as solvent. In the other experiments ohve oil was used.
TABLEVII.-Control Tmt8onSolventAlone(Lard).
One sarcoma only was obtained in these control tests on 366 mice. The
old C
" mice were 12 (and upwards) months of age at the start of the
experiments; their effective number should therefore be raised by a factor
of the order of 2 since the initial number, 19, would represent the survivors
at 12 months. The siingle sarcoma occurred in an oldC57moim at the unex-
pectedly low latent period of 6 months.* However, s'mce this mouse was
16 months of age at the start ofthe experiment some ageing factor for tumour
induction is obviously operating. M%en young mice are used, the average latent period is 19 months (Table IX).
Number of mice at start and survivors.
A
At Ist 6 9 12 15 18 21 24 27
injection. months. months. months. months. months. months. montbs. -months.
Stock 307 226 179 129 89 56 27 13 2
C57 40 31 30 26 22 22 10 3
Cr.7 (old) 19 13* 9 4 4 3Number of mice surviving.
--A-
't
134 . 107 95 90 77 45 25 6 2
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TABLE VIII.-Tests on Activity of Solvent (Olive Oil) Alone).
W57 mice were used.)
Experiments at Pollard's Wood inhydrocarbon-caxeinogen free laboratory.
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Start r
ofexpt.
4
5
4
4
5
3
3
3
3
4
4
3
4
4
3
3
3
3
3
4
3
6
6
5
6
6
6
6
6
6
6
6 m.
4
5
4
4
4
2
3
2
3
4
3
1
2
3
3
2
2
3
3
4
3
2
6
5
4
4
6
4
2
5
5
9 M.
4
5
4
4
4
2
3
2
3
3
3
0
2
2
3
2
2
3
1
4
3
2
5
4
4
4
5
4
1
4
3
I yr.
4
4
4
3
4
2
3
2
3
3
3
2
2
3
2
2
3
0
4
3
2
3
4
4
4
5
4
1
3
4
15 M.
2
2
4
2
4
2
3
2
1
3
3
2
2
3
2
2
3
4
3
2
2
18 m.
1
2
2
2
0
1
2
2
1
0
3
2
2
0
2
2
3
3
2
2
2
21 m.
0
2
2
1
0
1
0
1
2
2
0
1
1
9
3
2
2
2
0
0
0
1
0
0
24 m.
0
1
0
0
0
0
0
0
0
0
2
2
0
27 m.
2
Sarcomas.
1 (C57 .)
at 21at mtb.
4
4
3
3
4
1
3
2
2
0
1
2
1
1
2
0
1
TABLIF, IX-Latent Period8
Table No.
I
(including Section A)
of Table II)
II
(B and C)
III
IV
v
(excluding Section F which
is detailed in IV above)
viii
of Sarcoma8 Indiuced with ChOle8terol of Different
Degree8 of Purity.
Number of
sarcornas.
17
Latent periods
(months).
11, 13, 14, 14, 15, 16,
18, 18, 20, 22, 22, 23,
23, 23, 24, 24, 29
14, 15, 18, 18, 21
27
15, 18, 19, 20, 23
11, 12, 12, 16, 16, 16,
17, 19, 20, 20, 20, 20,
225- 24, 24, 27, 29
21
Mean
latent period.
19
5
1
5
17
1
46
17
27
19
19
21FLOW SHIMET I.
Unsaponified fraction of
human liver (partlv cancer
subjects, partlynon-cancer) a
resaponified and
extracted with
,I boiling MeOH
MeOH insoluble ...b
MeOH moderately soluble ...... c
MeOH soluble
filtered at 10)
mother liquors ......d
MeOH , -100 crystals .................................. e
resaponified and crystallised
from hot IVEeOH
mother liquors
......f
MeOH, hot, crystals ................................. g
crystallised from acetone
mother liquors
......h
acetone, crystals .......................................i
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U.V. Spectroscopic Examination of Chole8terol of Variou8 Degree8 of Purity.
Key to Ab8orption Spectrum Curve8 (Fig. 8).
Curve L-Chole8terol purified via dibromide and recrystalHsed from acetic
acid. (Not tested on mice).
Curve, 2.-Acetone cry8talli8edfraction ofchole8terolfractionfrom liver Stage i,
below). IAver, obtained post mortem from human subjects who had died of
cancer or from some other cause was saponified and treated according to the
flow sheet below.
Mice at
start.
15
15
10
After
I yr.
12
Sarcomas.
12 0
8 0
15 12 0
15 12 0
10 10 0
10 8 I
5 4 1
15 14 .-0
The low absorption shown by Curve 2 (low, that is, compared with the curve
for the commercial product) and its inactivity, carcmogenically, suggests that
treatment bv crystalhsing from acetone removes the active fraction. However,
it is difficult to explain why Fractions a and e, which contained all the subsequent
fractions, including i, did not induce tumours. When this process (crystallising from acetone) was apphed on a larger scale (Table 11) to commercial cholesterol
it was found that the active fraction was concentrated in the crystalline product
which was much more active than the mother liquors, and here the absorption
curve ofthe acetone crystal fraction (Ctirve 5) showedconsiderably lessabsorption
than did the cholesterol before treatment (Curve I1). Moreover, number 12 which
shows a depression where Curve 5 shows a hump is the absorption curve of a
careinogenically active preparation, (2 tumours in 20 mice (initially) using cho-
lesterolrefluxed with alcohohe KOH in anexperimentdesigned to test whether the
process of saponification itself confers activity on cholesterol). Therefore, theCARCINOGENIC ACTIVITY OF PURIFIED CHOLESTEROL 285
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FIG. 7.-The spectra of cholesterol fractions in CS2 ; all were measured in I nun. cell at a
concentration of 25 g.p.l. Described in the Appendix.
5. Least soluble fraction from 11.
9. Pure cholesterol.
I1. Corrimercial cholesterol: Glaxo, sample 1201.
13. Most soluble fraction from I1.
component responsible for absorption at the hump in Curve 5 (A about 235) does
not appear to be essential for careinogeinic activity. Furthermore, Curve 12
shows ahump at X about 275-285 where Curve 5 shows adeepdepression and since
bothpreparations wereactive, the componentresponsible for thishump canhardly
be essential.
Curve 3.-Cholesterol purified by bromination (Schoenheimer technique.
Prof C. W. Shoppee's preparation (see Table III.).
Curve. 4.-Unsaponifiable fraction of cream of cow's milk after crystallisation
from AfeOH at 10'. This preparation induced sarcomas in 2 mice from 20,
initially.
Curve 5.-Least soluble fraction from acetone crystalhsation of commercial
cliolesterol (No. BS 1201 ; Curve II). (See Table 11 for results of mouse tests).
Curve 6.-Product from acetylation, chromatography, de-acetylation and
crystalhsation of commercial cholesterol. No mouse test. The experiment was
designed to see how far bromination was necessary to depress the absorption of
the cholesterol.
Curve 7.-Same as Curve 6 except that bromination (foRowed by debromina-
tion) was introduced between acetylation and chromatography. No mouse test.
Curve 8.-Commercial cholesterol as used in tests detailed in Table V.
Curve 9.-Same as Curve 7 except that different portion ofthe elute at the
chromatographic stage was used for the subsequent stages.
Curve IO.-Largepreparation ofhighlypurified cholesterolusing the combined
techniques for Curves 7 and 9. See Table IV for results of animal test. The low
absorption of this preparation compared with that ofCurve 8 (commercial choles-286 I. HIEGER AND S. F. D. ORR
terol batch 5989) from which it was obtained and the close similarity ofthe carci-
nogenic activities ofthe two substances is one ofthe ihain arguments in support of
the theme of this paper.
Curve II.-Commercial cholesterol (Batch B.S. 1201) as used for some of the
tests detailed in Table I (Experiments 30-35) and also for thestarting out material
in Table IL
Curve 12.-Commercial cholesterol after refluxing with alcoholic KOH. This
preparation gave 2 sarcomas in 20 mice initiaRy. See notes to Curve 2.
Other work on carcinogenic activity of chole8terol.
Truhaut (1947) could find no activity in his sample of purified cholesterol.
Truhaut injected 20 mice, of unnamed genetic origin, with cholesterol
" purifie',"
20 mice with cholesterol irradiated with 10,000 r, and 20 with solvent alone,
namelv ohve oil. A lymphosarcoma (described as
" tumeur spontane'e ") arose
in the irradiated cholesterol group and a
" huilome
" in the non-irradiated choles-
terol -aroulD.
One sarcoma wasproduced, and that in the control group ofmiceinjected with
olive oil. Truhaut's (1947) comment on this tumour is:
" 11 doit donc 8'agir
d'une coincidence.
"
Truhaut (1947) does not give details of the method employed purifying the
cholesterol, nor of the survival rate of his experimental animals. In conclusion
he states :
" Si la susceptibilite' individuelle des animaux n'est pas en cause, cela
tendrait 'a d6monterlapre'sence, dans le choleste'rolcommercial,d'impurete's
fortement cance'rig'enes qm se rapprochent vraisemblablement des sub-
stancek; responsables de I'activite' cance'rig'ene de la fraction des ste'rols
precipitables par le digitonoside dans l'insaponifiable du foie de sujets
cancereux.
Steiner (1951) has alsoreported that nocarcinogenicactivity could be detected
in a sample of cholesterol. He gives no details of the strain and number of mice
used nor oftheir survival rate. He states :
Further studies of the carcinogenic activity in human tissue extracts
have demonstrated its presence in fractions that have no ultra-violet
absorption spectra characteristic of aromatic polycyclic hydrocarbons.
This may indicate a new class ofcarcinogenic compounds.
.c Studies of the carcinogen potentiahties of cholesterol revealed that
pure cholesterol was not carcinogenic."
However, Druckrey (personal communication to the writer) has found that his
sample ofcholesterol, which he obtained from Windaus, did give rise to tumours
on injection into mice.
DISCUSSION.
The main problem to be solved in this work is, whether the activity of the
cholesterol is to be attributed to the pure sterol itself, orsome companion (sterol
type), or to some other carcinogen, possibly ofhydrocarbon type, whetherpresent with the cholesterol from the time of its formation or introduced later duringCARCINOGENIC ACTIVlTY OF PURIFIED CHOLESTEROL 287
preparation. An examination of the absorption curves and the keys suggests
that removal oftheimpuritiesresponsible forabsorption inU. V. does notseriously
impair the carcinogenic activity. The low activity of one sample of purified
cholesterol (Curve 3, Prof. Shoppee's preparation) could be explained on the poor
survival rate of the mice in the test (Table III).
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FIG. 8.-The absorption curves for the samples of cholesterol used in the tests on mice, and
the effect on the absorption of different purification processes.288 I. HIEGER AND S. F. D. ORR
The tests with the commercial sample were done on stock mice and one.,7
mice; with the pure sample they were done onC57mice, on the expectation that
if pure and commercial cholesterol and the control (ohve off) series were tested
on the same pure hne strain ofmouse, more consistency would be attained. Table
VI shows that stock mice are more sensitive than are C57 mice, hence the assayed
activity of the pure cholesterol (carried out on C57 M'ee) should, theoretically,
be at least as high as that ofthe commercial cholesterol which was carried out on
stock mice.
Although the degree ofactivity of commercial cholesterol was much less at the
Pollard's Wood laboratory than in the tests with commercial cholesterol carried
,out at Chester Beatty Institute (Table I) it should be noted that:
(1) These tests, (Table V) were conducted in a hydrocarbon-carcinogen free
room. When the test was conducted in a room where the atmosphere might be
contaminated with hydrocarbon-carcinogen vapour, the incidence of tumours
was about as Iiigh as the incidence found at the Chester Beatty laboratory.
(2) A first-step purification by simple acetone crystalHsation of commercial
cholesterol was sufficient to appreciably decrease the absorption without affecting
the carcinogenic activity.
In the Chester Beatty tests (Tables I, II, III) lard was used as solvent ; in the
PoRard's Wood tests (Tables IV and V) olive oil was used as solvent.
(3) Thepartplayedby the solvent is notyet known. There may weH be some
co-carcinogenic effect between the sterol and the solvent.
(4) The responsible carcinogen may conceivably be a companion of cholesterol
which has too faint anabsorption (whetherby reason ofits lowintrinsicabsorption
capacity or because ofverylowconcentration) to bedistinguishedfromcholesterol,
or it may have the same spectroscopic characteristics as cholesterol. This
possibility cannot be ignored but it would then require to be postulated that the
companion faithfully foHows the cholesterol through aR the purification processes
(acetylation, bromination, etc.), that it is present in the cholesterol from human
tissue (cancerous human subject, as well as non-cancerous) and also in cows'
milk cream and in cattle brain and spinal cord. Alternatively it would be neces-
sary to postulate a plurahty ofcarcinogen companions of cholesterol derived from
different sources.
SUMMARY.
1. Commercial cholesterol purified byacetylation, bromination and chromato-
graphy togive aproduct with a very low U. V. absorption does not loseitscapacity
to induce sarcoma on injection, dissolved in oHve oil, into C.7mice. Five mice
developed sarcoma in a series of 172 treated mice ofwhich 126 survived more than
I year. In the control seriesinjected with solvent alone, I sarcoma was obtained
in a series of 134 C.7mice of which 90 survived more than 1 year.
2. The commercial cholesterol before purification induced one sarcoma in a
series of 60 C57 mice of which 28 survived I year. The same cholesterol solution
injected in stock mice kept under identical conditions induced 6 sarcomas in
135 mice ofwhich 95 survived more than I year.
3. Data a-re presented showing that stock mice are of the order of twice as
sensitive as C.7 M'Ce to carcinogenesis by commercial cholesterol.
4. The highest incidence of sarcomas obtained with commercial cholesterolCARCINOGENIC ACTIVITY OF PURIFIED CHOLESTEROL 289
was in experiments at the Chester Beatty Institute laboratories, where sarcoma
developed in 5 of 45 stock mice ofwhich 18 survived more than 1 year.
5. The sarcomas induced by cholesterol (commercial and purified) have a long
latent period. Forty-six sarcomas had an average latent period of 19 months.
6. Five hundred control mice were tested with the solvents alone (lard or
oliveoil). Ofthese 500, 249lived morethan 1 year. Twosarcomas wereobtained.
The authors are deeply indebted to Dr. Joan Booth for the ultra-violet
absorption spectra. Her data are an essential part of the material on which this
paper is based.
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APPENDIX.
INFRA-RED SPECTRA.
The purity of the cholesterol fractions has been further followed by infra-red
spectral measurements. Attention was directed to the spectra in the region
characteristic of double-bond absorption, namely at 1650-1750 cm.-'. In this
region, cholesterol itself has only the one weak band at 1665 cm.-' due to its
single ethylenic double-bond, so that the presence of carbonyl containing impu-
rities should be easily detected due to the relatively high intensity of absorption
of such groups.
From a study ofthe exact frequency ofthis bandin a largenumber ofcarbonyl-
containing steroids, it has been shown (Jones, Humphries and Dobriner, 1950) that
a strict correlation occurs, so that from the frequency ofthe band, the position of
the carbonyl group in the molecule can be deduced. Furthermore, it has been
bhown (Jones, Ramsay, Keir and Dobriner, 1952) that the intensity ofabsorption
per carbonyl group is constant for each particular type and is independant of
the rest of the molecule. From the carbonyl absorption found in cholesterol
fractions, therefore, the type of impurity and its approximate amount can be
deduced.
Cholesterol preparation numbers, 3, 4, 6, 7 and 9 (for key, vide supra) showed
no appreciable carbonyl absorption (less than 0-25 per cent). Number 8 (Glaxo
sample 5989) had a band at 1744 cm.-', assigned to a 17-ketone, equivalent to
about 1 per cent of such an impurity. Number 11 (Glaxo sample 1201) had three
bands at 1744, 1710 and 1674 cm-'; these indicate about 9 per centofa 17-ketone,
4 per cent of a 20-ketone (or possibly in a 6-membered ring) and 3 per cent of an
ac, unsaturated ketone, probably a A4: 3-ketone. Number 5, which was the
least soluble fraction obtained by fractional crystallisation of this latter commer-290 I. HIEGER AND S. F. D. ORR
cial sample had the same bands but reduced in intensity to about 3 ofthe original,
indicating a considerable purification ofthe cholesterol. The most soluble fraction
in this crystallisation and used for the test in Section D, Table II (number 13)
contained the impurities concentrated about five-fold. The progress of this
purification procedure can be followed in Fig. 7, which shows the relevant
spectra.
By comparison with the findings from the ultra-violet spectra, absorption at
235 m, appears to correspond to carbonyl absorption in the infra-red, but absorp-
tion at 251m,u, as in number 4, does not correspond to such absorption in the
infra-red; the main impurity in 4 must therefore be ofnon-carbonyl origin.
All infra-red spectra were measured in CS2 solution in 1 to 3 mm. cells on a
Perkin Elmer 12C spectrometer.
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